David J Tweardy

5PUBLICATIONS
19CO-AUTHORS
Predictive and prognostic markersMolecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 26, 2026
Colitis-Associated Colorectal Cancer-STAT3 Inhibition as a Preventive Strategy.

|Nov 13, 2025
STAT3 Inhibition to Treat Ulcerative Colitis-Associated Colorectal Cancer.

Prema Robinson, Zal Italia, Zara Italia

|Jan 10, 2025
Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors.

Apostolia M Tsimberidou, David J Vining, Sukeshi P Arora

|Oct 14, 2022
Aberrant function of pathogenic STAT3 mutant proteins is linked to altered stability of monomers and homodimers.

Moses M Kasembeli, Efiyenia Kaparos, Uddalak Bharadwaj

|Nov 02, 2016
Protein stabilization improves STAT3 function in autosomal dominant hyper-IgE syndrome.

Claire E Bocchini, Karen Nahmod, Panagiotis Katsonis

Pageof 1

Frequent Collaborators

2 joint publications

Uddalak Bharadwaj

2 joint publications

Leticia Hamana Zorrilla

2 joint publications

Tan Hoang

2 joint publications

Luisa Maren Solis Soto